Compare Pfizer with WYETH LTD - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

PFIZER vs WYETH LTD - Comparison Results

PFIZER     Change

Pfizer India is a 71% subsidiary of the world's largest pharmaceuticals company Pfizer Inc. Pfizer derives a larger share of its revenues from the pharmaceuticals division (81%). The company also has presence in the animal health (13%) and clinical d... More

WYETH LTD 
   Change

Wyeth Limited is the 51% subsidiary of Wyeth, US and is the sixth largest company among multinationals with revenues of Rs 2.9 bn in FY07. The company derives its revenues from pharmaceutical and OTC segments with focus on various therapeutic areas s... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    PFIZER WYETH LTD PFIZER/
WYETH LTD
 
P/E (TTM) x 36.5 27.7 131.5% View Chart
P/BV x 6.2 5.3 115.1% View Chart
Dividend Yield % 0.6 1.3 43.6%  

Financials

 PFIZER   WYETH LTD
EQUITY SHARE DATA
    PFIZER
Mar-19
WYETH LTD
Mar-13
PFIZER/
WYETH LTD
5-Yr Chart
Click to enlarge
High Rs3,8401,044 367.7%   
Low Rs2,080818 254.3%   
Sales per share (Unadj.) Rs455.0298.6 152.4%  
Earnings per share (Unadj.) Rs93.857.2 163.8%  
Cash flow per share (Unadj.) Rs109.458.4 187.3%  
Dividends per share (Unadj.) Rs22.5017.00 132.4%  
Dividend yield (eoy) %0.81.8 41.6%  
Book value per share (Unadj.) Rs658.2249.5 263.8%  
Shares outstanding (eoy) m45.7522.72 201.4%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x6.53.1 208.6%   
Avg P/E ratio x31.616.3 194.0%  
P/CF ratio (eoy) x27.115.9 169.7%  
Price / Book Value ratio x4.53.7 120.5%  
Dividend payout %24.029.7 80.8%   
Avg Mkt Cap Rs m135,42021,157 640.1%   
No. of employees `0002.60.5 534.8%   
Total wages/salary Rs m3,238400 809.6%   
Avg. sales/employee Rs Th7,911.413,787.4 57.4%   
Avg. wages/employee Rs Th1,230.9813.0 151.4%   
Avg. net profit/employee Rs Th1,630.72,643.3 61.7%   
INCOME DATA
Net Sales Rs m20,8156,783 306.9%  
Other income Rs m1,674353 474.7%   
Total revenues Rs m22,4897,136 315.1%   
Gross profit Rs m5,7121,617 353.2%  
Depreciation Rs m71427 2,683.8%   
Interest Rs m736 1,325.5%   
Profit before tax Rs m6,5991,938 340.5%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0-5 0.0%   
Tax Rs m2,309632 365.2%   
Profit after tax Rs m4,2911,301 329.9%  
Gross profit margin %27.423.8 115.1%  
Effective tax rate %35.032.6 107.2%   
Net profit margin %20.619.2 107.5%  
BALANCE SHEET DATA
Current assets Rs m27,1676,984 389.0%   
Current liabilities Rs m8,9172,056 433.7%   
Net working cap to sales %87.772.6 120.7%  
Current ratio x3.03.4 89.7%  
Inventory Days Days6899 68.3%  
Debtors Days Days3024 125.7%  
Net fixed assets Rs m8,862244 3,627.5%   
Share capital Rs m458227 201.4%   
"Free" reserves Rs m29,6565,441 545.1%   
Net worth Rs m30,1135,668 531.3%   
Long term debt Rs m2525 100.0%   
Total assets Rs m39,4007,901 498.7%  
Interest coverage x91.5353.3 25.9%   
Debt to equity ratio x00 18.8%  
Sales to assets ratio x0.50.9 61.5%   
Return on assets %11.116.5 67.0%  
Return on equity %14.222.9 62.1%  
Return on capital %22.134.0 65.0%  
Exports to sales %00.2 0.0%   
Imports to sales %036.3 0.0%   
Exports (fob) Rs mNA15 0.0%   
Imports (cif) Rs mNA2,465 0.0%   
Fx inflow Rs m42815 2,817.8%   
Fx outflow Rs m7862,677 29.4%   
Net fx Rs m-358-2,662 13.5%   
CASH FLOW
From Operations Rs m978923 105.9%  
From Investments Rs m351317 110.8%  
From Financial Activity Rs m-1,099-481 228.4%  
Net Cashflow Rs m231759 30.4%  

Share Holding

Indian Promoters % 0.0 0.0 -  
Foreign collaborators % 63.9 51.1 125.0%  
Indian inst/Mut Fund % 7.5 11.3 66.4%  
FIIs % 4.9 7.2 68.1%  
ADR/GDR % 0.0 0.0 -  
Free float % 23.7 30.4 78.0%  
Shareholders   85,207 21,978 387.7%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare PFIZER With:   AUROBINDO PHARMA  ORCHID PHARMA LTD  GSK PHARMA  J.B.CHEMICALS  PROCTER & GAMBLE HEALTH  

Compare PFIZER With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

CSB Bank IPO, October Passenger Vehicle Sales, and Top Cues in Focus Today(Pre-Open)

On Tuesday, Indian share markets witnessed buying interest during closing hours and ended on a positive note.

Related Views on News

PFIZER Announces Quarterly Results (2QFY20); Net Profit Up 61.0% (Quarterly Result Update)

Oct 29, 2019 | Updated on Oct 29, 2019

For the quarter ended September 2019, PFIZER has posted a net profit of Rs 2 bn (up 61.0% YoY). Sales on the other hand came in at Rs 6 bn (up 9.1% YoY). Read on for a complete analysis of PFIZER's quarterly results.

PFIZER Announces Quarterly Results (1QFY20); Net Profit Up 22.8% (Quarterly Result Update)

Aug 13, 2019 | Updated on Aug 13, 2019

For the quarter ended June 2019, PFIZER has posted a net profit of Rs 1 bn (up 22.8% YoY). Sales on the other hand came in at Rs 5 bn (up 6.3% YoY). Read on for a complete analysis of PFIZER's quarterly results.

PFIZER Announces Quarterly Results (4QFY19); Net Profit Up 4.7% (Quarterly Result Update)

May 29, 2019 | Updated on May 29, 2019

For the quarter ended March 2019, PFIZER has posted a net profit of Rs 1 bn (up 4.7% YoY). Sales on the other hand came in at Rs 5 bn (up 3.0% YoY). Read on for a complete analysis of PFIZER's quarterly results.

PFIZER Announces Quarterly Results (3QFY19); Net Profit Up 51.2% (Quarterly Result Update)

Jan 25, 2019 | Updated on Jan 25, 2019

For the quarter ended December 2018, PFIZER has posted a net profit of Rs 1 bn (up 51.2% YoY). Sales on the other hand came in at Rs 5 bn (up 12.5% YoY). Read on for a complete analysis of PFIZER's quarterly results.

PFIZER 2017-18 Annual Report Analysis (Annual Result Update)

Jan 1, 2019 | Updated on Jan 1, 2019

Here's an analysis of the annual report of PFIZER for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of PFIZER. Also includes updates on the valuation of PFIZER.

More Views on News

Most Popular

Crash Alert! Is There a Big Bubble in Nestle, HUL and Asian Paints?(Profit Hunter)

Nov 7, 2019

Is this the beginning of the end of multibagger gains in quality stocks like Nestle, HUL, and Asian Paints?

The Smartest Stock to Buy for 2020(Profit Hunter)

Nov 14, 2019

Small-cap stocks are selling at bargain prices today and are poised to generate a lot of wealth in 2020 and beyond...

Why Moody's Rating Downgrade is a Strong Sign to Buy Stocks(The 5 Minute Wrapup)

Nov 8, 2019

Investors who took cues from Moody's rating downgrade in 1992 and 2002 created some of the biggest wealth of their lifetime.

A Trade that Could Generate Profits for Decades

Nov 14, 2019

India's #1 trader is back on the Investor Hour. Vijay Bhambwani talks to us about his super-profitable trading system and shares with us his #1 long term trade. Listen in...

The One Trade I'm Most Bullish on Now

Nov 12, 2019

A highly specific trade to potentially triple your money in just three months. You won't find this information anywhere else!

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

PFIZER SHARE PRICE


Nov 19, 2019 (Close)

TRACK PFIZER

COMPARE PFIZER WITH

MARKET STATS